Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells - Topaly, Julian; Zeller, W. Jens; Frühauf, Stefan (Leukemia, 2001)
Gesehen am 26.01.2022